Search research articles
Contact Us
Filters
Showing results (151-160 of 169) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Caterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Cancer Medicine
|
December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Sara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Cancers
|
August 27, 2021
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
Marta Giussani, Chiara Maura Ciniselli, Loris De Cecco, et al.
Journal of Neuro-Oncology
|
May 17, 2018
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Maura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Journal of Neuro-Oncology
|
April 4, 2014
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Maura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Molecular Oncology
|
November 24, 2021
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial
Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 9, 2019
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study
Serena Di Cosimo, Tiziana Triulzi, Sara Pizzamiglio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 11, 2023
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
Luca Forlani, Loris De Cecco, Vittorio Simeon, et al.
NPJ Precision Oncology
|
November 17, 2025
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial
Eliana Pivetta, Vincenzo Canzonieri, Marina Bagnoli, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 169) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Caterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Cancer Medicine
|
December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Sara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Cancers
|
August 27, 2021
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
Marta Giussani, Chiara Maura Ciniselli, Loris De Cecco, et al.
Journal of Neuro-Oncology
|
May 17, 2018
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Maura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Journal of Neuro-Oncology
|
April 4, 2014
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Maura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Molecular Oncology
|
November 24, 2021
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial
Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 9, 2019
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study
Serena Di Cosimo, Tiziana Triulzi, Sara Pizzamiglio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 11, 2023
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
Luca Forlani, Loris De Cecco, Vittorio Simeon, et al.
NPJ Precision Oncology
|
November 17, 2025
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial
Eliana Pivetta, Vincenzo Canzonieri, Marina Bagnoli, et al.
Page
of 17